Trulieve Cannabis (TRLV) Liabilities and Shareholders Equity (2020 - 2026)

Trulieve Cannabis has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $2.1 billion in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 28.9% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $10.5 billion, a 9.15% decrease from a year earlier, with the FY2025 full-year figure at $2.7 billion, down 6.07% from the prior year.
• Liabilities and Shareholders Equity was $2.1 billion for Q2 2026 at Trulieve Cannabis, down from $2.8 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $3.5 billion in Q1 2022, with the low at $2.1 billion in Q2 2026.
• Average Liabilities and Shareholders Equity over 5 years is $2.9 billion, with a median of $2.9 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity soared 85682.16% in 2022, then slipped 28.9% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $3.4 billion in 2022, then fell by 19.74% to $2.7 billion in 2023, then climbed by 5.17% to $2.9 billion in 2024, then fell by 6.07% to $2.7 billion in 2025, then retreated by 22.95% to $2.1 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.1 billion (Q2 2026), $2.8 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.